ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681645 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681645; 2) Community: the network communities that were significantly associated with the response to NSC 681645; 3) Molecule: the relationships between components within communities and NSC 681645; 4) MDR: the compounds that were significantly associated with the NSC 681645.

NSC Compound Enrichment Correlation
NSC 610458 Camptothecin Derivative 0.000100168541082771 0.87214814
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.000100168541082771 0.47496279
NSC 681635 Camptothecin Derivative 0.000100168541082771 0.89051325
NSC 681639 Camptothecin Derivative 0.000100168541082771 0.91592517
NSC 653255 1-Cyano-2-(3',4',5'-trimethoxybenzyl)-10-N-methylphenothiazine 0.000108541161925035 0.32941856
NSC 676345 Pyrimidine-2,4-diamine, 6-chloro-N(4)- [[1-(hydroxymethyl)-3-(2-phenylethyl)cyclobutyl]methyl]- 0.000108541161925035 0.21934774
NSC 691849 Null 0.000207411843201371 0.73230005
NSC 660027 Null 0.000209334878795459 0.56861472
NSC 681643 Camptothecin Derivative 0.000209334878795459 0.94687674
NSC 681646 Camptothecin Derivative 0.000209334878795459 0.93071767
Total:67  Current:1    [First] [Prev] [Next] [Last]